Evidence map›Paper›PMID 25769246›Full record

ArticleAmerican journal of ophthalmology2015

Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome.

Douglas A Jabs, Mark L Van Natta, Efe Sezgin, Jeong Won Pak, Ronald Danis, Studies of the Ocular Complications of AIDS Research Group

Registry-linked trialAbstract read
In one paragraph

Article in American journal of ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00000168 (Studies of Ocular Complications of AIDS), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00000168 completednot on this map

Studies of Ocular Complications of AIDS (SOCA)

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan1998 to 2013Enrolled2,392ConditionsHIV Infections, Acquired Immunodeficiency Syndrome, Cytomegalovirus Retinitis
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Douglas A JabsDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Center for Clinical Trials, Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland. Electronic address: douglas.jabs@mssm.edu.
Mark L Van NattaCenter for Clinical Trials, Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
Efe SezginCenter for Clinical Trials, Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
Jeong Won PakDepartment of Ophthalmology, University of Wisconsin, Madison, Madison, Wisconsin.
Ronald DanisDepartment of Ophthalmology, University of Wisconsin, Madison, Madison, Wisconsin.
Studies of the Ocular Complications of AIDS Research Group
Johns Hopkins University · USUniversity of Wisconsin–Madison · USIcahn School of Medicine at Mount Sinai · US

Funding

Studies of Ocular Complications of AIDS - Coordinating CenterU10EY008057 · NEI · JOHNS HOPKINS UNIVERSITY · PI VAN NATTA, MARK L · 1988 to 2012
$78.0M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Studies of Ocular Complications of AIDS - Chairman's OfficeU10EY008052 · NEI · JOHNS HOPKINS UNIVERSITY · PI JABS, DOUGLAS A · 1988 to 2012
$8.0M
Studies of Ocular Complications of AIDS - Reading CenterU10EY008067 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI DANIS, RONALD · 1988 to 2012
$3.2M
NEI NIH HHS U10 EY008067NEI NIH HHS U10 EY 08052NEI NIH HHS U10 EY 08057NEI NIH HHS U10 EY 08067NIAID NIH HHS P30 AI 094189NIAID NIH HHS P30 AI094189
6 · The paper itself

Abstract

purposeTo evaluate the prevalence of intermediate-stage age-related macular degeneration (AMD) in patients with acquired immunodeficiency syndrome (AIDS).

designCross-sectional study of patients with AIDS enrolled in the Longitudinal Study of the Ocular Complications of AIDS.

methodsIntermediate-stage AMD was determined from enrollment retinal photographs by graders at a centralized Reading Center, using the Age-Related Eye Disease Study grading system. Graders were masked as to clinical data.

resultsOf 1825 participants with AIDS and no ocular opportunistic infections, 9.9% had intermediate-stage AMD. Risk factors included age, with an odds ratio (OR) of 1.9 (95% confidence interval [CI] 1.6, 2.3, P < .001) for every decade of age; the prevalence of AMD ranged from 4.0% for participants 30-39 years old to 24.3% for participants ≥60 years old. Other risk factors included the human immunodeficiency virus (HIV) risk groups of injection drug use (OR = 2.4, 95% CI 1.5, 3.9, P < .001) or heterosexual contact (OR = 1.9, 95% CI 1.3, 2.8, P = .001). Compared with the HIV-uninfected population in the Beaver Dam Offspring Study, there was an approximate 4-fold increased age-adjusted prevalence of intermediate-stage AMD.

conclusionsPatients with AIDS have an increased age-adjusted prevalence of intermediate-stage AMD compared with that found in a non-HIV-infected cohort evaluated with similar methods. This increased prevalence is consistent with the increased prevalence of other age-related diseases in antiretroviral-treated, immune-restored, HIV-infected persons when compared to non-HIV-infected persons.

Indexed as

Acquired Immunodeficiency SyndromeAdultAgedAged, 80 and overAntiviral AgentsCD4 Lymphocyte CountCD4-Positive T-LymphocytesCross-Sectional StudiesFemaleHumansMacular DegenerationMaleMiddle AgedPrevalenceRetinal DrusenRisk FactorsAntiviral Agents

Identifiers

PMID25769246
PMCPMC6126535
OpenAlexW129307454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.